POINT ROBERTS, WA.; January 26,2005 -www.BiodefenseStocks.com, an investor news portal for the Biodefense sector within the HomelandDefenseStocks.com (HDS) content umbrella, reports on the recent news reported by the World Health Organization (WHO) that work has begun on building a 200 million-dose stockpile of smallpox vaccine to prepare for a possible bioterror attack. Smallpox is an acute contagious disease caused by the variola virus and without vaccination we are susceptible to infection, with a thirty percent potential mortality rate. Separate from vaccines, one public company is developing a treatment countermeasure that captures smallpox related viruses and toxins directly from human blood.
